Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Seres Therapeutics (MCRB) Long-Term Debt Issuances (2022 - 2023)

Seres Therapeutics (MCRB) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $103.4 million as the latest value for Q2 2023.

  • Quarterly Long-Term Debt Issuances changed N/A to $103.4 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $103.4 million through Sep 2024, changed 0.0% year-over-year, with the annual reading at $103.4 million for FY2023, 274.48% up from the prior year.
  • Long-Term Debt Issuances hit $103.4 million in Q2 2023 for Seres Therapeutics, up from $27.6 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $103.4 million in Q2 2023 to a low of $27.6 million in Q1 2022.